Compounds > 2,3-bis(3'-hydroxybenzyl)butyrolactone
Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and Adenosis of Breast

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Adenosis of Breast in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boccardo, F; Lunardi, GL; Petti, AR; Rubagotti, A1
Boccardo, F; Guglielmini, P; Lunardi, G; Murialdo, R; Parodi, M; Rubagotti, A; Schettini, G1

Trials

1 trial(s) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Adenosis of Breast

ArticleYear
Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk.
    Breast cancer research and treatment, 2003, Volume: 79, Issue:1

    Topics: 4-Butyrolactone; Adult; Aged; Breast Neoplasms; Epidermal Growth Factor; Exudates and Transudates; Female; Fibrocystic Breast Disease; Humans; Lignans; Middle Aged; Odds Ratio; Predictive Value of Tests; Risk Factors; Statistics as Topic

2003

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Adenosis of Breast

ArticleYear
Serum enterolactone levels and the risk of breast cancer in women with palpable cysts.
    European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:1

    Topics: 4-Butyrolactone; Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fibrocystic Breast Disease; Follow-Up Studies; Humans; Lignans; Middle Aged; Regression Analysis; Retrospective Studies; Risk Factors; Serum

2004